Gene · 2673
Papers1,425
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,425
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Unique Intercellular Feedforward Loop From HK1 to TGF-β1 Promotes the Progression of Hepatocellular Carcinoma. | J Extracell Vesicles | 2026 | 41806338 | PubTator, text mining | PubMed |
| GFPT2 drives sunitinib resistance of renal cell carcinoma via enzyme-dependent and -independent manners. | Int J Biol Sci | 2026 | 41800253 | PubTator, text mining | PubMed |
| Immunometabolism in lung cancer - The link between metabolism and immune response. | iScience | 2026 | 41797927 | PubTator, text mining | PubMed |
| Unravelling the pathophysiology of diabetic foot ulcer: insights into a complex wound healing process. | Front Clin Diabetes Healthc | 2026 | 41789125 | PubTator, text mining | PubMed |
| Dysfunctional decidual CD2+CD4+T cells regulated by Rev-erbα - GFPT1 - GPI anchored CD58 axis of decidual stromal cells underlies sleep disturbance induced recurrent pregnancy loss. | Front Immunol | 2026 | 41789068 | PubTator, text mining | PubMed |
| The extracellular matrix in inflammation and cancer. | Mol Biomed | 2026 | 41787034 | PubTator, text mining | PubMed |
| Genomic analysis of dental pulp mesenchymal stromal cells for therapeutic applications. | Regen Ther | 2026 | 41777871 | PubTator, text mining | PubMed |
| Glutamine Supplementation and Exercise: A Narrative Review of Biochemical Mechanisms and Timing Strategies. | Medicina (Kaunas) | 2026 | 41752728 | PubTator, text mining | PubMed |
| Innovative strategies for diabetic peripheral neuropathy: From clinical management to emerging bioengineering solutions. | Bioact Mater | 2026 | 41737633 | PubTator, text mining | PubMed |
| Endothelial Metabolic Reprogramming Links Diabetes to Atherosclerosis. | Diabetes Metab Syndr Obes | 2026 | 41710712 | PubTator, text mining | PubMed |
| Reducing OGT and O-GlcNAcylation enhance the anticancer effects of oxaliplatin in SW620 metastatic colorectal cancer cells. | PLoS One | 2026 | 41666153 | PubTator, text mining | PubMed |
| Epigenetic and post-translational regulatory networks of ferroptosis in the tumor immune microenvironment. | Exp Hematol Oncol | 2026 | 41588554 | PubTator, text mining | PubMed |
| Destabilization of lipoma-preferred partner by TGF-β-induced O-GlcNAcylation promotes hepatocellular carcinoma metastasis. | Biochim Biophys Acta Mol Cell Res | 2026 | 41587621 | PubTator, text mining | PubMed |
| A novel case of compound heterozygous GFPT1 congenital myasthenic syndrome with a coexisting heterozygous DYSF mutation: clinical and pathological insights. | Neurol Sci | 2026 | 41546777 | PubTator, text mining | PubMed |
| LncRNA ELFN1-AS1 maintains the stemness of colorectal cancer by preventing ubiquitinated degradation of the hnRNPA1 protein. | Cell Mol Life Sci | 2026 | 41535615 | PubTator, text mining | PubMed |
| Congenital Myasthenic Syndrome: Long-Term Outcomes up to 60 Years, Molecular Characterization, and Eight Novel Variants. | Clin Genet | 2026 | 41451794 | PubTator, text mining | PubMed |
| A Cohort of Iranian Patients With Congenital Myasthenic Syndrome due to Glycosylation Defects. | Muscle Nerve | 2026 | 41312578 | PubTator, text mining | PubMed |
| Glucose metabolic dysregulation of diabetes and Its role in atrial fibrillation pathogenesis. | Front Cardiovasc Med | 2025 | 41799894 | PubTator, text mining | PubMed |
| Integrated Multi-omics Analysis of Hub Genes and miRNA Interactions in Hypertrophic Cardiomyopathy. | Curr Genomics | 2025 | 41450821 | PubTator, text mining | PubMed |
| Glutamine: fructose-6-phosphate amidotransferase (GFAT) in the pathology of diseases: a review. | Cell Death Discov | 2025 | 41390473 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2673/papers?page=2